Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter S. Klein currently holds 19,226 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter S. Klein has been a net seller of DNLI stock. They have purchased $0 and sold $1.4M worth of shares.
Peter S. Klein's most recent insider trade was on Jun 3, 2026, when they sold 19,226 shares at $0.00 per share.
Peter S. Klein serves as Executive at Denali Therapeutics Inc. (DNLI). They have executed 62 insider transactions totaling $1.4M over their tenure at the company.
Peter S. Klein holds the position of Executive at Denali Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Peter S. Klein has shown a selling trading pattern, with $0 in total purchases and $1.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter S. Klein was on Sep 10, 2018, when they sold $310.1K worth of APTI shares. This transaction involved 8,000 shares at $38.76 per share.
Peter S. Klein currently owns 19,226 shares of Denali Therapeutics Inc. (DNLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter S. Klein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter S. Klein has 62 Form 4 filings on record as an insider at Denali Therapeutics Inc..
Set alerts for Peter S. Klein and 40,000+ other insiders.